These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11724689)

  • 1. Strategies for raising HDL cholesterol.
    Harv Heart Lett; 2001 Nov; 12(3):5-6. PubMed ID: 11724689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 3. [New drug against lipid disorders. HDL level rises 30%].
    MMW Fortschr Med; 2003 Sep; 145(39):51. PubMed ID: 14649076
    [No Abstract]   [Full Text] [Related]  

  • 4. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
    Tavintharan S; Lim SC; Sum CF
    Singapore Med J; 2005 Oct; 46(10):519-28. PubMed ID: 16172771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol-raising strategies.
    Kuvin JT; Alsheikh-Ali AA; Karas RH
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):196-204. PubMed ID: 16495756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.
    Toth PP
    Am J Cardiol; 2005 Nov; 96(9A):50K-58K; discussion 34K-35K. PubMed ID: 16291015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Powerful HDL booster available OTC.
    Health News; 2005 Apr; 11(4):5. PubMed ID: 15818764
    [No Abstract]   [Full Text] [Related]  

  • 8. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HDL-C: a secondary target of dyslipidemia therapy.
    Rosenson RS
    Am J Med; 2005 Oct; 118(10):1067-77. PubMed ID: 16194634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On call. In your January 2007 article on cholesterol, you said that no-flush niacin does not lower cholesterol levels. But my problem is low HDL cholesterol. Will no-flush niacin help my HDL even if it won't lower my LDL cholesterol?
    Simon HB
    Harv Mens Health Watch; 2007 Jun; 11(11):7-8. PubMed ID: 17644843
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM; Davidson MH; McKenney J; Keller LH; Bajorunas DR; Karas RH
    Am J Cardiol; 2008 May; 101(10):1428-36. PubMed ID: 18471454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).
    Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J
    Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
    J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Even if LDL and triglycerides are within normal limits, low HDL increases risk of infarction].
    MMW Fortschr Med; 2004 May; 146(21):59. PubMed ID: 15373089
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of dyslipidemias: practical guidelines for the primary care physician.
    Bays HE; Dujovne CA; Lansing AM
    Heart Dis Stroke; 1992; 1(6):357-65. PubMed ID: 1344132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can cardiovascular events be prevented by raising HDL cholesterol?].
    Langslet G; Reikvam A
    Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1519-23. PubMed ID: 18587459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant supplements and simvastatin-niacin therapy.
    Netke S; Ivanov V; Roomi W; Niedzwiecki A; Rath M
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2099-100. PubMed ID: 11742891
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.